LORELCO

LOE Approaching

probucol

NDAORALTABLETPriority Review
Approved
Feb 1977
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
8

Clinical Trials (5)

NCT01726816Phase 2Completed

Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy

Started Oct 2012
126 enrolled
Diabetic Nephropathy
NCT01291641Phase 4Completed

Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease

Started Mar 2011
342 enrolled
Hyperlipidemias
NCT01142284Phase 2Completed

Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety

Started May 2010
80 enrolled
Peripheral Artery Disease
NCT02730390N/ACompleted

Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance

Started Dec 2009
3,087 enrolled
Hyperlipidemia
NCT01031667Phase 4Completed

Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study)

Started Nov 2009
118 enrolled
Therapy